Atorvastatin does not inhibit clopidogrel in patients undergoing coronary stenting in randomized data from the interactions of atorvastatin and clopidogrel (INTERACTION) trial

被引：0
|
作者：
Serebruany, VL
Midel, MG
Malinin, AI
Lowry, DR
Oshrine, BR
Steinhubl, SR
O'Connor, CM
Hennekens, CH
机构：
[1] Sinai Hosp, Thrombosis Res Ctr, Baltimore, MD USA
[2] Univ N Carolina, Chapel Hill, NC 27514 USA
[3] Duke Univ, Clin Res Inst, Durham, NC 27710 USA
[4] Univ Miami, Miami, FL 33152 USA
来源：
EUROPEAN HEART JOURNAL | 2003年 / 24卷
关键词：
D O I：
10.1016/S0195-668X(03)93725-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] Clopidogrel does not optimally inhibit platelet aggregation in patients undergoing percutaneous coronary intervention. Observations from the DEACON study
    Saucedo, JF
    Aude, W
    Garza, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 10L - 11L
  • [32] The potential interaction of statins and clopidogrel in patients undergoing percutaneous coronary intervention
    Ibrahim, Tahani H.
    Alanazy, Hind S.
    Alharbi, Maram M.
    Ahmed, Safa M.
    INTERNATIONAL JOURNAL OF ADVANCED AND APPLIED SCIENCES, 2021, 8 (03): : 112 - 119
  • [33] Clopidogrel therapy in patients undergoing coronary stenting:: value of a high loading dose regimen
    Kastrati, A
    Mehilli, J
    Gawaz, M
    Neumann, FJ
    Seyfarth, M
    Braun, S
    Dirschinger, J
    Schömig, A
    EUROPEAN HEART JOURNAL, 2001, 22 : 386 - 386
  • [34] Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting
    Weltermann, A
    Fritsch, P
    Kyrle, PA
    Schoenauer, V
    Heinze, G
    Wojta, J
    Christ, G
    Huber, K
    THROMBOSIS RESEARCH, 2003, 112 (1-2) : 19 - 24
  • [35] Current Evidence for Genetic Testing in Clopidogrel-Treated Patients Undergoing Coronary Stenting
    Sibbing, Dirk
    Bernlochner, Isabell
    Kastrati, Adnan
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (05) : 505 - 513
  • [36] Clopidogrel therapy in patients undergoing coronary stenting:: Value of a high loading dose regimen
    Kastrati, A
    Mehilli, J
    Dotzer, F
    Pache, J
    Bollwein, H
    Schühlen, H
    Dirschinger, J
    Schömig, A
    CIRCULATION, 2001, 104 (17) : 347 - 347
  • [37] Long-term versus short-term clopidogref therapy in patients undergoing coronary stenting (from the Randomized Argentine Clopidogrel Stent [RACS] trial)
    Bernardi, Victor
    Szarfer, Jorge
    Summay, Gabriel
    Mendiz, Oscar
    Sarmiento, Ricardo
    Rodriguez Alemparte, Maximo
    Gabay, Jose
    Berger, Peter B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (03): : 349 - 352
  • [38] Omeprazole, atorvastatin or combined drug therapy and 1-year clopidogrel drug therapy efficacy after successful coronary stenting
    Georgilas, A. Theodosis
    Zairis, M.
    Patsourakos, N.
    Ritsatos, C.
    Kontos, C.
    Hatzissavvas, J.
    Tsiaousis, G.
    Beldekos, D.
    Fakiolas, C.
    Foussas, S.
    EUROPEAN HEART JOURNAL, 2010, 31 : 392 - 392
  • [39] Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
    Kreutz, Rolf P.
    Breall, Jeffrey A.
    Sinha, Anjan
    von der Lohe, Elisabeth
    Kovacs, Richard J.
    Flockhart, David A.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 45 - 50
  • [40] Lack of Clopidogrel-Statin Interaction in Patients Undergoing Coronary Stent Implantation
    Serrano Junior, Carlos Vicente
    Soeiro, Alexandre de Matos
    Araujo, Leila Fernandes
    Jabot, Bruna
    Rached, Fabiana
    Orii, Noemia Mie
    Nicolau, Jose Carlos
    Duarte, Alberto J.
    Ramires, Jose Antonio F.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 95 (03) : 321 - 327
12345